Long term follow up study and prevention of ATL occurrence among HTLV-1 carriers : a nationwide cohort study
Long term follow up study and prevention of ATL occurrence among HTLV-1 carriers : a nationwide cohort study
批准号:
17015047
负责人:
山口 一成
金额:
$58.75万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2009
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There are still 1.0 million HTLV-1 carriers in Japan. Definitive risk factors for ATL development from carrier status remain unclear. To investigate viral- and host-specific determinants of the development of ATL among HTLV-1 carriers. A nationwide cohort study for HTLV-1 carriers named the Joint Study on Predisposing Factors of ATL Development (JSPFAD) comprising of 41 institutions. Participants were HTLV-1 carriers who provided written informed consent. HTLV-1 proviral load (VL) and sIL-2R were measured annually. Demographic characteristics and clinical data were also collected annually. We evaluated 1218 HTLV-1 carriers (426 males and 792 females) who were enrolled during 2002-2008. VL at enrollment was significantly higher in males than females (median, 2.10 vs 1.39 copies/100PBMC), in those aged 40-49 and 50-59 yrs than that of those aged < ; 40 yrs (P=0.02 and 0.007, respectively), and in those with a family history of ATL than those without the history (median, 2.32 vs 1.33 copies/100PBMC) (P=0.005). During follow-up as of September 2009, 14 participants progressed to overt ATL. Their baseline VL was high (range, 4. 17-28.58 copies/100PBMC). None developed ATL among those with a baseline VL lower than < ; 4 copies/100PBMC. Multivariate Cox analyses indicated that not only a higher VL but also advanced age, family history of ATL, and first opportunity for HTLV-1 testing during treatment for other diseases were independent risk factors for progression of ATL from carrier status
期刊论文(64)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null)(NOD) mice.
将人嗜 T 淋巴细胞病毒 1 型携带者的外周血单核细胞移植到 NOD/SCID/gamma(null)(NOD) 小鼠中。
DOI:
--
发表时间:
2007
期刊:
Int J Cancer 121(10)
影响因子:
--
作者:
[Takajo I, Umeki K, Morishita K, Yamamoto I, Kubuki Y, Hatakeyama K, Kataoka H, Okayama A.]
通讯作者:
Okayama A.
DOI:
10.1182/blood-2009-09-242347
发表时间:
2010-06-03
期刊:
BLOOD
影响因子:
20.3
作者:
[Takasaki, Yumi, Iwanaga, Masako, Tsukasaki, Kunihiro]
通讯作者:
Tsukasaki, Kunihiro
Down-regulation of CDKN1A in adult T cell leukemia/lymphoma despite overexpression of CDKN1A in HTLV-1-infected cell lines.
尽管在 HTLV-1 感染的细胞系中 CDKN1A 过度表达,但成人 T 细胞白血病/淋巴瘤中 CDKN1A 下调。
DOI:
--
发表时间:
2010
期刊:
J Virol
影响因子:
5.4
作者:
[Watanabe M, Nakahata S, Hamasaki M, Saito Y, Kawano Y, Hidaka T, Yamashita K, Umeki K, Taki T, Taniwaki M, Okayama A, Mori shita K]
通讯作者:
Mori shita K
Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area.
大东京地区居民易感染 HTLV-1 的因素。
DOI:
--
发表时间:
2008
期刊:
Int J Hematol 88
影响因子:
--
作者:
[Uchimaru K, Nakamura Y, Tojo A, Watanabe T, Yamaguchi K.]
通讯作者:
Yamaguchi K.
In vitro and in vivo antitumor activity of the NF-kB inhibitor DHMEQ in the human T-cell leukemia virus type I-transformed cell line, HUT-102
NF-kB 抑制剂 DHMEQ 在人 T 细胞白血病病毒 I 型转化细胞系 HUT-102 中的体外和体内抗肿瘤活性
DOI:
--
发表时间:
2006
期刊:
Leuk Res 30
影响因子:
--
作者:
[Matsuura N, Miyamae Y, et al., Ohsugi T et al.]
通讯作者:
Ohsugi T et al.
共 46 条
ATL発症高危険群の長期追跡と発病予防の検討
-
批准号:12218104
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$77.18万
-
财政年份:2000
-
负责人:山口 一成
-
依托单位:
HTLV-I抗体陽性者の長期追跡
-
批准号:09252102
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas (A)
-
资助金额:$26.88万
-
财政年份:1999
-
负责人:山口 一成
-
依托单位:
HTLV-I抗体陽性者の長期追跡
-
批准号:06280117
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$8.96万
-
财政年份:1994
-
负责人:山口 一成
-
依托单位:
HTLV-I感染症の病態の解明と治療への新しい試み
-
批准号:01614529
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$6.4万
-
财政年份:1989
-
负责人:山口 一成
-
依托单位:
電子線照射ラット下顎部における新鮮自家骨移植後の血管新生に関する研究
-
批准号:59771530
-
项目类别:Grant-in-Aid for Encouragement of Young Scientists (A)
-
资助金额:$0.51万
-
财政年份:1984
-
负责人:山口 一成
-
依托单位:
ヒト尿中より抽出したBリンパ球増加因子について
-
批准号:56771172
-
项目类别:Grant-in-Aid for Encouragement of Young Scientists (A)
-
资助金额:$0.61万
-
财政年份:1981
-
负责人:山口 一成
-
依托单位:
国内基金
海外基金
登录
查看更多内容
pH响应型靶向ATL@Fe-MOF@M纳米载体在胆囊癌双模式成像指导下光热/化学动力协同免疫治疗的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
遗传性感觉神经病中ATL3突变致轴索末梢内质网功能障碍的机制研究
-
批准号:LZ23H090004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:赵国华
-
依托单位:
拟南芥E3泛素连接酶ATL5调控种子寿命的作用机制研究
-
批准号:32070349
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:陈喜文
-
依托单位:
拟南芥E3泛素连接酶ATL17调控脱落酸抑制主根生长的分子机制研究
-
批准号:31870248
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:郝福顺
-
依托单位: